Sarcouncil Journal of Medical Sciences

Abstract: Background and Purpose: Elevation of serum cardiac troponin is thought to be a particular indicator of acute coronary syndrome. Is shown to be elevated in acute ischemic stroke patients; nevertheless, its etiology and importance remain debatable. Our study's objective is to determine the connections between high blood troponin levels and the severity and outcome of strokes. Patients and Method: The study included 220 patients who were admitted to the Al-Sadder Medical City at Al-Najaf Al-Ashraf within 3 days of the onset of acute ischemic stroke (AIS), as confirmed clinically through a brain computed tomography scan, among June 2023 - June 2024. All patients had blood troponin assay, and they were divided in two categories: those with positive troponin (n = 33) as well as those with negative troponin (n = 187). The severity of the stroke was assessed using the National Institutes in Health Stroke Score, and the patient's survival and death within 14 days of the stroke's onset were recorded. Results: only 15% of patients had increased serum troponin, and higher troponin levels were linked to more severe strokes. The group that tested positive for troponin had a worse short-term prognosis than the group that tested negative. In the hospital, 17 patients passed away. Nine patients had negative troponin test results, whereas eight had positive results. Conclusion: those with normal (not increased) serum troponin levels and those with acute ischemic stroke who had high serum troponin levels experienced poorer outcomes (death within 2 weeks) and significant neurological sequelae at the outset of the stroke.